MedTrace Logo

Quantitative Sensory Testing and Central Sensitization in Endometriosis

NCT06215937 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-08-07

No results posted yet for this study

Summary

Endometriosis is a gynecologic condition where there is growth of endometrial-like tissue outside the uterus, leading to severe pelvic pain. Despite conventional treatment, many patients experience persistent pelvic pain due to central sensitization (CS), where the central nervous system amplifies pain signals. Quantitative Sensory Testing (QST) enables objective testing of CS. However, there are several patient-reported questionnaires that have shown promising potential as subjective proxies of CS.

Therefore, in this study, our objective is to validate six patient-reported questionnaires as measures of CS by comparing them to each other and determining whether each questionnaire correlates with QST thresholds.

Conditions

  • Endometriosis
  • Pain

Interventions

OTHER

No Intervention

No intervention

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • BC Women's Hospital & Health Centre

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06215937 on ClinicalTrials.gov